Take the first step to a better outcome.
Join our network and access additional resources.
Give your members exceptional care when it matters most.
11/16/2018
Byline: Elaine Goodman Publication: WorkCompCentral Date: Friday, November 16, 2018
Intrathecal pumps, drug-delivery systems that have been controversial in workers’ compensation, are the subject of a warning issued Thursday by the U.S. Food and Drug Administration.
The FDA has cautioned against using the pumps to deliver drugs that aren’t approved…
Login required to read the full article here: Unapproved Drugs Add to Intrathecal Pump Risk
